• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

15 Companies with (Expected) Quick Returns

Article

Some investors are just too impatient to wait 10, 15 or 20 years to see returns. Here are 15 stocks that should pay off by July 2013.

Not everybody wants to get into the stock market for the next 10, 15 or 20 years. It may be riskier, but some investors are little more impatient; they’re looking for a quicker turnaround for their stock investments.

This week, Morgan Stanley published a list of 15 stocks that should see superior risk-adjusted returns by July 2013. The companies listed here have over $750 million in market capitalization.

Business Insider

“Based on their analysis, these stocks exhibited the best combination of favorable risk-reward profiles and clear catalysts,” wrote .

There are three health care companies on the list. And while some might be unsurprising, like Apple, it was a little more surprising to see JPMorgan here after the disastrous trade that cost the company more than $2 billion. However, Morgan is expecting that JPMorgan’s stock will re-start again over the next few weeks.

Here are 15 stocks for impatient investors (listed in alphabetical order).

Anadarko Petroleum

Ticker: APC

Sector: Basic materials

Price target: $103

Current price: $67.46

Price-to-earnings ratio: 17.7

Apple

Ticker: AAPL

Sector: Technology

Price target: $738

Current price: $610.80

Price-to-earnings ratio: 12.6

Calpine

Ticker: CPN

Sector: Energy/Utilities

Price target: $27

Current price: 16.74

Price-to-earnings ratio: N/A

Honeywell International

Ticker: HON

Sector: Consumer Discretionary/Industrials

Price target: $68

Current price: $56.18

Price-to-earnings ratio: 11.7

JPMorgan Chase

Ticker: JPM

Sector: Financials

Price target: $54

Current price: $34.52

Price-to-earnings ratio: 8.4

Kraft Foods

Ticker: KFT

Sector: Consumer Staples

Price target: $44

Current price: $39.20

Price-to-earnings ratio: 15.3

Marsh & McLennan

Ticker: MMC

Sector: Financials

Price target: $39

Current price: $32.77

Price-to-earnings ratio: 14.4

Penn National Gaming

Ticker: PENN

Sector: Consumer Discretionary/Industrials

Price target: $52

Current price: $44.99

Price-to-earnings ratio: 17.3

Thermo Fisher Scientific

Ticker: TMO

Sector: Health Care

Price target: $65

Current price: $52.76

Price-to-earnings ratio: 10.3

UnitedHealth Group

Ticker: UNH

Sector: Health Care

Price target: $70

Current price: $56.11

Price-to-earnings ratio: 11.9

United Technologies

Ticker: UTX

Sector: Consumer Discretionary/Industrials

Price target: $95

Current price: $75.65

Price-to-earnings ratio: 13.5

VF Corp.

Ticker: VFC

Sector: Retail

Price target: $180

Current price: $134.86

Price-to-earnings ratio: 14.4

Visa

Ticker: V

Sector: Technology

Price target: $147

Current price: $127.23

Price-to-earnings ratio: 20.7

Watson Pharmaceuticals

Ticker: WPI

Sector: Health Care

Price target: $84

Current price: $75.57

Price-to-earnings ratio: 12.3

Williams Companies

Ticker: WMB

Sector: Energy/Utilities

Price target: $38

Current price: $29.17

Price-to-earnings ratio: 20.2

Read more:

Morgan Stanley: The 15 Best Stocks for Impatient Investors

Glaxo’s Stock Unaffected by $3B Settlement

Can the First Half’s Big Winners Stay Strong?

The information contained in this article should not be construed as investment advice or as a solicitation to buy or sell any stock.

Related Videos
Victor J. Dzau, MD, gives expert advice
Victor J. Dzau, MD, gives expert advice